Angeline Serena, Tiyatiye Babangida, Akosile Wole
Prince Charles Hospital, Metro North Mental Health, Brisbane, Queensland, Australia.
Perth Clinic, School of Medicine, The University of Western Australia, Perth, Western Australia, Australia.
Brain Behav. 2025 Feb;15(2):e70304. doi: 10.1002/brb3.70304.
Repetitive transcranial magnetic stimulation (TMS) has gained interest as a treatment for major depressive disorder (MDD). However, the literature on its efficacy and safety for pregnant patients with MDD is limited. This article reviews and appraises available studies on TMS in pregnant women with MDD.
We reviewed randomized controlled trials and open-label studies on TMS in pregnant women with MDD.
Studies indicate that TMS is a safe and effective treatment for MDD during pregnancy, showing significant reductions in depression scores and increased response and remission rates compared to sham TMS. TMS was well tolerated with minimal side effects.
Larger, multicenter trials are needed to develop evidence-based protocols for TMS use in pregnancy.
重复经颅磁刺激(TMS)作为治疗重度抑郁症(MDD)的一种方法已引起关注。然而,关于其对患有MDD的孕妇的疗效和安全性的文献有限。本文回顾并评估了关于TMS治疗患有MDD的孕妇的现有研究。
我们回顾了关于TMS治疗患有MDD的孕妇的随机对照试验和开放标签研究。
研究表明,TMS是孕期治疗MDD的一种安全有效的方法,与假TMS相比,抑郁评分显著降低,反应率和缓解率提高。TMS耐受性良好,副作用极小。
需要开展更大规模的多中心试验,以制定基于证据的孕期TMS使用方案。